01Jan/23
Key Molecular Targets Identified for Fighting Against Human Pancreatic Cancer
Today, pancreatic cancer remains one of the most lethal malignancies facing the global population. The 5-year survival rate for patients with pancreatic ductal adenocarcinoma (PDAC) is only about 3%, and PDAC isRead More…